Senate Finance Committee Wages Bipartisan Effort Across Branches of Government to Relieve Patients and Pharmacies from Pharmacy DIR Fees Pharmacy welcomes letter from over 80 percent of Committee members to Trump Administration, urging closure of Medicare regulatory loophole as legislative push continues

By |2019-09-12T13:01:36-05:00Sep-12-19|Categories: Press Release|Tags: , , , |

Pharmacy welcomes letter from over 80 percent of Committee members to Trump Administration, urging closure of Medicare regulatory loophole as legislative push continues

Pharmacy Urges Decisive Action to Close DIR Fee Loophole, Appreciates Senate Finance Committee’s Initial Bipartisan Movement on Issue “DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”

By |2019-07-25T17:02:08-05:00Jul-25-19|Categories: Press Release|Tags: , , , |

“DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”

105 U.S. Reps., 28 U.S. Senators Urge Trump Administration to Fix Pharmacy DIR Fees Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies

By |2019-06-20T11:49:41-05:00Jun-20-19|Categories: Press Release|Tags: , , , |

Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies.

Pharmacy United in Call for President Trump to Act on DIR Fee Reform Bipartisan support is strong for a legislative fix to the loophole that inflates drug costs for patients and for Medicare, and that jeopardizes pharmacies

By |2019-06-19T11:00:59-05:00Jun-10-19|Categories: Press Release|Tags: , , |

Bipartisan support is strong for a legislative fix to the loophole that inflates drug costs for patients and for Medicare, and that jeopardizes pharmacies.